Current Signal Transduction Therapy
Title: Editorial [Hot topic: Therapeutic Potential of O-GlcNAc Glycosylation Related Signaling Pathways (Guest Editor: Prof. Dr. Brigitte Schmitz)]
Volume: 5 Issue: 1
Author(s): Brigitte Schmitz
Affiliation:
Export Options
About this article
Cite this article as:
Schmitz Brigitte, Editorial [Hot topic: Therapeutic Potential of O-GlcNAc Glycosylation Related Signaling Pathways (Guest Editor: Prof. Dr. Brigitte Schmitz)], Current Signal Transduction Therapy 2010; 5 (1) . https://dx.doi.org/10.2174/1574362411005010001
DOI https://dx.doi.org/10.2174/1574362411005010001 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNAs and the Warburg Effect: New Players in an Old Arena
Current Gene Therapy Proteostasis, an Emerging Therapeutic Paradigm for Managing Inflammatory Airway Stress Disease
Current Molecular Medicine Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma
Current Pharmaceutical Biotechnology Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-associated Pneumonia Caused by Multidrugresistant Bacteria: A Randomized, Single-blind Clinical Trial
Infectious Disorders - Drug Targets State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Current Clinical Pharmacology Transcriptional Regulation of Glucose Sensors in Pancreatic β Cells and Liver
Current Diabetes Reviews Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer
Current Medicinal Chemistry Development and Validation of HPLC Method for Five Gliptins in Pharmaceutical Dosage Forms in Finished Marketed Products
Current Pharmaceutical Analysis From Endothelial Dysfunction to Arterial Stiffness in Diabetes Mellitus
Current Diabetes Reviews Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development
Current Drug Discovery Technologies Systems Biology of HBOC-Induced Vasoconstriction
Current Drug Discovery Technologies Serine Protease Inhibitor Kazal Type 1 (SPINK1): Beyond the Trypsin Inhibitor
Current Enzyme Inhibition The Impact of Diabetes Mellitus on Coronary Artery Disease: New Therapeutic Approaches
Current Pharmaceutical Design Reduction of Sympathetic Hyperactivity by Agents that Inhibit the Renin Angiotensin Aldosterone System
Current Hypertension Reviews Higher Expression of NOD1 and NOD2 is Associated with Vogt-Koyanagi-Harada (VKH) Syndrome But Not Behcet’s Disease (BD)
Current Molecular Medicine Autoantibodies Associated with Psychiatric Disorders
Current Neurovascular Research Medical Treatment of Symptomatic Diabetic Neuropathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Important New Drug Target in Cardiovascular Medicine – the Vascular Glycocalyx
Cardiovascular & Hematological Disorders-Drug Targets Podocytes as a Target of Insulin
Current Diabetes Reviews Clinical Use of Aspirin in Ischemic Heart Disease: Past, Present and Future
Current Pharmaceutical Design